Therapeutic areas

To get ahead of disease, we prioritise research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the science aligns with our strategic approach. 

Explore our therapeutic areas

Almost half of the vaccines and medicines under development are for infectious diseases, helping to protect people against diseases such as meningitis, shingles, influenza, polio, measles and many others.

More on infectious diseases at global level

Our work on HIV is in collaboration with ViiV, the world's only specialist HIV pharmaceutical company. Our long-acting HIV drugs have the potential to radically change people's experience by giving them an alternative to regular drugs.

More HIV at global level

We are developing life-changing cancer drugs for patients with ovarian cancer, endometrial cancer and multiple myeloma. We have accelerated this research and currently have several marketed therapies and several other assets in development.

More about cancer drugs and oncology treatments at global level

Our interest in the science of the immune system is helping us to develop vaccines and drugs for a range of immune diseases, including the first new drug for lupus, a chronic autoimmune disease, in 50 years.

More on our treatments in immunology at global level

 We also pursue other opportunity-driven therapies where the science aligns with our strategic approach. This includes the work we are doing to help the one in seven of the 700 million people with chronic kidney disease and anaemia.

More on opportunity-driven therapies at global level

Our awareness campaigns

Female toddler playing with toys in a house

Childhood Meningitis Campaign

Find out about GSK's campaign to raise awareness of meningitis in children and vaccination against this rare disease.

Learn more about meningitis (French and Dutch website)

Visuel poumons en bonne santé

COPD Campaign

Find out about GSK's COPD (Chronic Obstructive Pulmonary Disease) campaign to raise awareness of the symptoms and risks associated with this disease.

Learn more on COPD (French and Dutch website)

Learn more on our innovation at global level with our "Behind the Science" magazine.

"Behind the Science" magazine